Quantification of angiogenesis in breast cancer by automated vessel identification in CD34 immunohistochemical sections

Anticancer Research

Volumn 31, Issue 12, 2011, Pages 4053-4060

  Mikalsen, Lars Tore Gyland ^a   Dhakal, Hari Prasad ^a   Bruland, Øyvind S ^a,b   Nesland, Jahn M ^a   Olsen, Dag Rune ^c  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF BERGEN   (Norway)

Author keywords

Angiogenesis; Breast cancer; CD34; Image analysis; MVD; Vessel identification

Indexed keywords

ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; CD34 SELECTION; CELL COUNT; CONTROLLED STUDY; DISEASE COURSE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MICROSCOPY; MICROVASCULATURE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; SENSITIVITY ANALYSIS;

ANTIGENS, CD34; AUTOMATION; BREAST NEOPLASMS; CARCINOMA; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84855182001     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Folkman J: What is the evidence that tumors are angiogenesis dependent? JNCI 82: 4-6, 1990.
2. Offersen BV, Borre M and Overgaard J: Quantification of angiogenesis as a prognostic marker in human carcinomas: a critical evaluation of histopathological methods for estimation of vascular density. Eur J Cancer 39: 881-890, 2003. (Pubitemid 36428619)
3. Hlatky L, Hahnfeldt P and Folkman J: Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn't tell us. JNCI 94: 883-893, 2002. (Pubitemid 34778087)
4. Dhakal HP, Naume B, Synnestvedt M, Borgen E, Kaaresen R, Schlichting E, Wiedswang G, Bassarova A, Giercksky KE and Nesland JM: Vascularization in primary breast carcinomas: its prognostic significance and relationship with tumor cell dissemination. Clin Cancer Res 14: 2341-2350, 2008. (Pubitemid 351551066)
5. Hansen S, Grabau DA, Sorensen FB, Bak M, Vach W and Rose C: Vascular grading of angiogenesis: prognostic significance in breast cancer. Br J Cancer 82: 339-347, 2000. (Pubitemid 30045379)
6. Nieto Y, Woods J, Nawaz F, Baron A, Jones RB, Shpall EJ and Nawaz S: Prognostic analysis of tumour angiogenesis, determined by microvessel density and expression of vascular endothelial growth factor, in high-risk primary breast cancer patients treated with high-dose chemotherapy. Br J Cancer 97: 391-397, 2007. (Pubitemid 47196747)
7. Uzzan B, Nicolas P, Cucherat M and Perret GY: Microvessel density as a prognostic factor in women with breast cancer: a systematic review of the literature and meta-analysis. Cancer Res 64: 2941-2955, 2004. (Pubitemid 38581387)
8. Weidner N, Semple JP, Welch WR and Folkman J: Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N Engl J Med 324: 1-8, 1991.
9. Weidner N: Tumoural vascularity as a prognostic factor in cancer patients: The evidence continues to grow. J Pathol 184: 119-122, 1998.
10. Hansen S, Sorensen FB, Vach W, Grabau DA, Bak M and Rose C: Microvessel density compared with the Chalkley count in a prognostic study of angiogenesis in breast cancer patients. Histopathology 44: 428-436, 2004. (Pubitemid 38725671)
11. Offersen BV, Sorensen FB, Yilmaz M, Knoop A and Overgaard J: Chalkley estimates of angiogenesis in early breast cancer - relevance to prognosis. Acta Oncol 41: 695-703, 2002. (Pubitemid 36106216)
12. Vermeulen PB, Gasparini G, Fox SB, Colpaert C, Marson LP, Gion M, Belien JA, de Waal RM, Van Marck E, Magnani E, Weidner N, Harris AL and Dirix LY: Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours. Eur J Cancer 38: 1564-1579, 2002. (Pubitemid 34876495)
13. Fitzgibbons PL, Page DL, Weaver D, Thor AD, Allred DC, Clark GM, Ruby SG, O'Malley F, Simpson JF, Connolly JL, Hayes DF, Edge SB, Lichter A and Schnitt SJ: Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 124: 966-978, 2000.
14. Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred EN, Moore DH, Meli S and Gasparini G: Tumor angiogenesis - a new significant and independent prognostic indicator in early-stage breast-carcinoma. JNCI 84: 1875-1887, 1992. (Pubitemid 23004615)
15. Gasparini G: Clinical significance of determination of surrogate markers of angiogenesis in breast cancer. Crit Rev Oncol Hematol 37: 97-114, 2001.
16. Fox SB, Leek RD, Weekes MP, Whitehouse RM, Gatter KC and Harris AL: Quantitation and prognostic value of breast cancer angiogenesis: comparison of microvessel density, Chalkley count, and computer image analysis. J Pathol 177: 275-283, 1995.
17. Dhakal HP, Bassarova A, Naume B, Synnestvedt M, Borgen E, Kaaresen R, Schlichting E, Wiedswang G, Giercksky KE and Nesland JM: Breast carcinoma vascularity: a comparison of manual microvessel count and Chalkley count. Histol Histopathol 24: 1049-1059, 2009.
18. Sharma S, Sharma MC and Sarkar C: Morphology of angiogenesis in human cancer: a conceptual overview, histoprognostic perspective and significance of neoangiogenesis. Histopathology 46: 481-489, 2005. (Pubitemid 40632304)
19. Safali M, Karslioglu Y, Arpaci F, Kurt B and Gunhan O: A distinct microvascular pattern accompanied by aggressive clinical course in breast carcinomas: a fact or a coincidence? Pathol Res Pract 206: 93-97, 2010.
20. Korkolopoulou P, Konstantinidou AE, Kavantzas N, Patsouris E, Pavlopoulos PM, Christodoulou P, Thomas-Tsagli E and Davaris P: Morphometric microvascular characteristics predict prognosis in superficial and invasive bladder cancer. Virchows Arch 438: 603-611, 2001. (Pubitemid 32662380)
21. Weidner N: Chapter 14. Measuring intratumoral microvessel density. Methods Enzymol 444: 305-323, 2008.
22. Weyn B, Tjalma WA, Vermeylen P, van Daele A, Van Marck E and Jacob W: Determination of tumour prognosis based on angiogenesis-related vascular patterns measured by fractal and syntactic structure analysis. Clin Oncol (R Coll Radiol) 16: 307-316,2004. (Pubitemid 38696973)
23. Goutzanis LP, Papadogeorgakis N, Pavlopoulos PM, Petsinis V, Plochoras I, Eleftheriadis E, Pantelidaki A, Patsouris E and Alexandridis C: Vascular fractal dimension and total vascular area in the study of oral cancer. Head Neck 31: 298-307, 2009.
24. van Niekerk CG, van der Laak JA, Borger ME, Huisman HJ, Witjes JA, Barentsz JO and Hulsbergen-van de Kaa CA: Computerized whole-slide quantification shows increased microvascular density in pT2 prostate cancer as compared to normal prostate tissue. Prostate 69: 62-69, 2009.
25. Naume B, Borgen E, Kvalheim G, Karesen R, Qvist H, Sauer T, Kumar T and Nesland JM: Detection of isolated tumor cells in bone marrow in early-stage breast carcinoma patients: comparison with preoperative clinical parameters and primary tumor characteristics. Clin Cancer Res 7: 4122-4129, 2001. (Pubitemid 34048337)
26. Naume B, Wiedswang G, Borgen E, Kvalheim G, Karesen R, Qvist H, Janbu J, Harbitz T and Nesland JM: The prognostic value of isolated tumor cells in bone marrow in breast cancer patients: evaluation of morphological categories and the number of clinically significant cells. Clin Cancer Res 10: 3091-3097, 2004. (Pubitemid 38619688)
27. Wiedswang G, Borgen E, Karesen R, Kvalheim G, Nesland JM, Qvist H, Schlichting E, Sauer T, Janbu J, Harbitz T and Naume B: Detection of isolated tumor cells in bone marrow is an independent prognostic factor in breast cancer. J Clin Oncol 21: 3469-3478, 2003. (Pubitemid 46594079)
28. Python programming language version (2.6.6); Python Software Foundation. [Online]. URL: http://www.python.org/ last accessed on October 28, 2011.
29. Jones E, Oliphant T and Peterson P: SciPy version (0.8.0): Open Source Scientific Tools for Python. URL: http://www.scipy.org/ last accessed on October 28, 2011.
30. Otsu N: Threshold selection method from gray-level histograms. IEEE Trans Systems Man Cybernetics 9: 62-66, 1979.
31. Kittler J and Illingworth J: Minimum error thresholding. Pattern Recog 19: 41-47, 1986.
32. Bland JM and Altman DG: Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1: 307-310, 1986. (Pubitemid 16134762)
33. Bland JM and Altman DG: Applying the right statistics: analyses of measurement studies. Ultrasound Obstet Gynecol 22: 85-93, 2003. (Pubitemid 36886457)
34. Shrout PE and Fleiss JL: Intraclass correlations: uses in assessing rater reliability. Psychol Bull 86: 420-428, 1979.
35. Fox SB, Generali DG and Harris AL: Breast tumour angiogenesis. Breast Cancer Research 9: 216, 2007.
36. Kerbel RS: Tumor angiogenesis. N Engl J Med 358: 2039-2049, 2008.
37. Belien JA, Somi S, de Jong JS, van Diest PJ and Baak JP: Fully automated microvessel counting and hot spot selection by image processing of whole tumour sections in invasive breast cancer. J Clin Pathol 52: 184-192, 1999. (Pubitemid 29125410)
38. Fox SB and Harris AL: Histological quantitation of tumour angiogenesis. APMIS 112: 413-430, 2004. (Pubitemid 39626050)
39. Vermeulen PB, Gasparini G, Fox SB, Toi M, Martin L, McCulloch P, Pezzella F, Viale G, Weidner N, Harris AL and Dirix LY: Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation. Eur J Cancer 32A: 2474-2484, 1996.
40. Wild R, Ramakrishnan S, Sedgewick J and Griffioen AW: Quantitative assessment of angiogenesis and tumor vessel architecture by computer-assisted digital image analysis: effects of VEGF-toxin conjugate on tumor microvessel density. Microvasc Res 59: 368-376, 2000. (Pubitemid 30322264)
41. Ranefall P, Wester K, Busch C, Malmstrom PU and Bengtsson E: Automatic quantification of microvessels using unsupervised image analysis. Analyt Cell Path 17: 83-92, 1998. (Pubitemid 29067547)
42. Goddard JC, Sutton CD, Furness PN, Kockelbergh RC and O'Byrne KJ: A computer image analysis system for microvessel density measurement in solid tumours. Angiogenesis 5: 15-20, 2002. (Pubitemid 36076919)
43. Kim NT, Elie N, Plancoulaine B, Herlin P and Coster M: An original approach for quantification of blood vessels on the whole tumour section. Analyt Cell Pathol 25: 63-75, 2003. (Pubitemid 36443406)
44. Mertz KD, Demichelis F, Kim R, Schraml P, Storz M, Diener PA, Moch H and Rubin MA: Automated immunofluorescence analysis defines microvessel area as a prognostic parameter in clear cell renal cell cancer. Hum Pathol 38: 1454-1462, 2007. (Pubitemid 47418973)
45. Righi M, Giacomini A, Lavazza C, Sia D, Carlo-Stella C and Gianni AM: A computational approach to compare microvessel distributions in tumors following antiangiogenic treatments. Lab Invest 89: 1063-1070, 2009.
46. Brawer MK, Deering RE, Brown M, Preston SD and Bigler SA: Predictors of pathologic stage in prostatic carcinoma. The role of neovascularity. Cancer 73: 678-687, 1994. (Pubitemid 24046612)
47. Simpson JF, Ahn C, Battifora H and Esteban JM: Endothelial area as a prognostic indicator for invasive breast carcinoma. Cancer 77: 2077-2085, 1996. (Pubitemid 26142052)
48. van der Laak JA, Westphal JR, Schalkwijk LJ, Pahlplatz MM, Ruiter DJ, de Waal RM and de Wilde PC: An improved procedure to quantify tumour vascularity using true colour image analysis. Comparison with the manual hot-spot procedure in a human melanoma xenograft model. J Pathol 184: 136-143, 1998. (Pubitemid 28088420)
49. van Der Laak JA, Pahlplatz MM, Hanselaar AG and de Wilde PC: Hue-saturation-density (HSD) model for stain recognition in digital images from transmitted light microscopy. Cytometry 39: 275-284, 2000. (Pubitemid 30212603)